meta_pixel
Tapesearch Logo
Log in
The Curbsiders Internal Medicine Podcast

#96 Diabetes: A1C targets & ACP guidelines controversy

The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

Health & Fitness, Medicine, Science, Higher Education, Education

4.83.1K Ratings

🗓️ 21 May 2018

⏱️ 50 minutes

🧾️ Download transcript

Summary

Get schooled on hemoglobin a1c targets in type 2 diabetes mellitus by American College of Physicians guidelines coauthor, Devan Kansagara MD MCR, Associate Professor of Medicine, Oregon Health Sciences University. We summarize outcomes from the landmark diabetes trials (ACCORD, ADVANCE, VADT, UKPDS 33 & 34), how a1c targets effect microvascular and macrovascular events, estimating life expectancy, and how to personalize diabetes control for your patients. We’re proud to announce our new partnership with the ACP to provide free CME credit and MOC points on select episodes of The Curbsiders. ACP members can visit acponline.org to redeem free CME/MOC credit.

Full show notes available at http://thecurbsiders.com/podcast

Join our mailing list to receive a PDF copy of our show notes every Monday. Rate us on iTunes, recommend a guest or topic and give feedback at [email protected].


Credits:
  • Written, produced, and edited by: Matthew Watto MD.
  • Hosts: Stuart Brigham MD, Paul Williams MD, Matthew Watto MD.
  • Guest: Devan Kansagara MD, MCR

Time Stamps
  • 00:00 Announcement
  • 00:48 Disclaimer and intro
  • 03:11 Getting to know our guest: one liner, book recommendation, mentorship
  • 06:50 How and why did ACP write their guidance statement on diabetes, A1C targets
  • 09:18 Landmark trials in type 2 diabetes
  • 11:36 Does tight control prevent micro or macrovascular complications
  • 13:20 Trials of newer agents like SGLT2i, GLP-1 and DPP4i
  • 14:33 How do ACP’s guidelines differ from other published guidelines
  • 17:20 Quick recap of landmark trial findings
  • 22:24 Personalizing glycemic control
  • 24:30 Controversy over an A1C goal of 7-8%
  • 28:05 Clinical inertia
  • 30:26 Legacy effect and metabolic memory
  • 34:00 Deintensifying therapy
  • 38:29 Life expectancy and comorbid conditions
  • 43:15 Performance measures in diabetes
  • 44:42 Take-home points
  • 46:30 The Curbsiders recap and give some closing remarks
  • 49:13 Outro

Transcript

Click on a timestamp to play from that location

0:00.0

The first cyber-photos is for entertainment education and information processing.

0:09.2

And the topics discussed should not be used only by industry,

0:10.7

your orbit and industry is more in conditions.

0:12.0

But more than you would say it's expressed on the cyber-photos,

0:13.5

although those should not be interpreted perfectly

0:14.5

for official policy or position of the agency,

0:15.5

the cyber-photos, the cash-like morons will end up in the outreach programs.

0:17.4

Indeed, there are any in fact there are none.

0:18.9

Pretty much we are responsible for this,

0:19.9

but we do our homework and let's know when we're done.

0:21.4

Welcome back to the Curve Siders.

0:28.4

Well, hi Matt, how are you doing?

0:38.9

I'm doing well, hi Stewart.

0:41.4

Here with my two co-host, Stewart Brigham, who you just heard,

0:44.9

and also Paul, you there?

0:47.9

Yeah, I'm here.

0:48.9

Hi, Paul.

0:50.9

How are the kids, Paul?

0:52.9

Hi, mediocre children, here are fine, thank you.

0:55.9

Paul, why don't you tell the audience in case we have some new listeners?

1:00.9

What we do on this show?

1:02.9

Happy to, Matt.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Curbsiders Internal Medicine Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Curbsiders Internal Medicine Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.